We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UIP Recommended for Approval After Form 483
UIP Recommended for Approval After Form 483
November 2, 2009
An FDA district office has submitted a recommendation of approval to CDER for the University of Iowa Pharmaceuticals (UIP) to manufacture an aseptically
filled sterile prescription drug product for a commercial client, according to a university statement.